Apollo Hospitals

55
Hold
  • Market Cap: Large Cap
  • Industry: Hospital
  • ISIN: INE437A01024
  • NSEID: APOLLOHOSP
  • BSEID: 508869
INR
7,193.05
-5.3 (-0.07%)
BSENSE

Dec 05

BSE+NSE Vol: 2.64 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Consolidated - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
No of Months
12
12
12
12
12
12
Operating Income
21,794.00
19,059.00
16,612.00
14,662.00
10,560.00
11,246.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
0.00
0.00
0.00
Net Sales
21,794.00
19,059.00
16,612.00
14,662.00
10,560.00
11,246.00
Expenditure (Ex Depriciation)
Stock Adjustments
-1.00
-33.00
-24.00
-73.00
-125.00
-107.00
Raw Materials Consumed
11,311.00
9,839.00
8,598.00
7,646.00
5,809.00
5,605.00
Power & Fuel Cost
266.00
247.00
217.00
193.00
169.00
213.00
Employee Cost
2,769.00
2,493.00
2,176.00
1,786.00
1,601.00
1,852.00
Operating Expenses
2,396.00
2,089.00
1,786.00
1,582.00
878.00
939.00
General and Administration Expenses
-1.00
-1.00
-1.00
-1.00
-1.00
-1.00
Selling and Distribution Expenses
531.00
658.00
639.00
364.00
199.00
227.00
Cost of Software developments
0.00
0.00
0.00
0.00
0.00
0.00
Miscellaneous Expenses
188.00
141.00
141.00
137.00
136.00
139.00
Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
18,772.00
16,668.00
14,562.00
12,477.00
9,422.00
9,659.00
Operating Profit (PBDIT) excl Other Income
3,021.00
2,390.00
2,049.00
2,185.00
1,137.00
1,587.00
Other Income
200.00
106.00
90.00
78.00
45.00
27.00
Operating Profit (PBDIT)
3,222.00
2,497.00
2,139.00
2,263.00
1,182.00
1,614.00
Interest
458.00
449.00
380.00
378.00
449.00
532.00
Profit before Depriciation and Tax
2,763.00
2,047.00
1,759.00
1,884.00
733.00
1,081.00
Depreciation
757.00
687.00
615.00
600.00
573.00
619.00
Profit Before Taxation & Exceptional Items
2,006.00
1,360.00
1,143.00
1,284.00
160.00
461.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Profit Before Tax
2,039.00
1,380.00
1,143.00
1,578.00
220.00
660.00
Provision for Tax
534.00
445.00
256.00
477.00
84.00
225.00
Profit After Tax
1,472.00
917.00
887.00
1,101.00
136.00
434.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
0.00
0.00
Profit Balance B/F
2,772.00
2,059.00
1,600.00
593.00
426.00
370.00
Profit Available for appropriations
4,218.00
2,957.00
2,419.00
1,648.00
576.00
825.00
Appropriations
4,218.00
2,957.00
2,419.00
1,648.00
576.00
825.00
Equity Dividend (%)
253.20%
320.00%
300.00%
235.00%
60.00%
120.00%
Earnings Per Share
100.56
62.50
56.97
73.42
10.74
32.70
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is 14.35% vs 14.73% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is 26.40% vs 16.64% in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is 2.02% vs 18.01% in Mar 2024

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2025 is 60.53% vs 3.32% in Mar 2024

Compare Profit and Loss Results of Apollo Hospitals
Markets Mojo
Figures in Cr
consolidated - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
21,794.00
5,406.00
16,388.00
303.14%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
21,794.00
5,406.00
16,388.00
303.14%
Expenditure (Ex Depriciation)
Stock Adjustments
-1.00
0.00
-1.00
0%
Raw Materials Consumed
11,311.00
1,119.00
10,192.00
910.81%
Power & Fuel Cost
266.00
77.00
189.00
245.45%
Employee Cost
2,769.00
934.00
1,835.00
196.47%
Operating Expenses
2,396.00
1,271.00
1,125.00
88.51%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
531.00
66.00
465.00
704.55%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
188.00
69.00
119.00
172.46%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
18,772.00
3,913.00
14,859.00
379.73%
Operating Profit (PBDIT) excl Other Income
3,021.00
1,492.00
1,529.00
102.48%
Other Income
200.00
178.00
22.00
12.36%
Operating Profit (PBDIT)
3,222.00
1,670.00
1,552.00
92.93%
Interest
458.00
59.00
399.00
676.27%
Profit before Depriciation and Tax
2,763.00
1,610.00
1,153.00
71.61%
Depreciation
757.00
244.00
513.00
210.25%
Profit Before Taxation & Exceptional Items
2,006.00
1,365.00
641.00
46.96%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
2,039.00
1,365.00
674.00
49.38%
Provision for Tax
534.00
307.00
227.00
73.94%
Profit After Tax
1,472.00
1,057.00
415.00
39.26%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
2,772.00
1,234.00
1,538.00
124.64%
Profit Available for appropriations
4,218.00
2,291.00
1,927.00
84.11%
Appropriations
4,218.00
2,291.00
1,927.00
84.11%
Equity Dividend (%)
253.2%
15%
238.20
Earnings Per Share
100.56
10.89
89.67
823.42%
Profit And Loss - Net Sales
Net Sales 21,794.00 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 14.35% vs 14.73% in Mar 2024

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 3,021.80 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 26.40% vs 16.64% in Mar 2024

Profit And Loss - Interest
Interest 458.50 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 2.02% vs 18.01% in Mar 2024

Profit And Loss - Profit After Tax
Profit After Tax 1,472.10 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 60.53% vs 3.32% in Mar 2024